Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Modest von Korff

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Chemical Information and Modeling|January 19, 2012
Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screeningModest von Korff, Joel Freyss, Thomas Sander, et al.
Journal of Chemical Information and Modeling|May 13, 2009
OSIRIS, an entirely in-house developed drug discovery informatics systemThomas Sander, Joel Freyss, Modest von Korff, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Integration of distributed computing into the drug discovery processModest von Korff, Christian Rufener, Manuel Stritt, et al.
Chimia|October 27, 2017
The Screening Compound Collection: A Key Asset for Drug DiscoveryChristoph Boss, Julien Hazemann, Thierry Kimmerlin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Chemical Information and Modeling|January 19, 2012
Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screeningModest von Korff, Joel Freyss, Thomas Sander, et al.
Journal of Chemical Information and Modeling|May 13, 2009
OSIRIS, an entirely in-house developed drug discovery informatics systemThomas Sander, Joel Freyss, Modest von Korff, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Integration of distributed computing into the drug discovery processModest von Korff, Christian Rufener, Manuel Stritt, et al.
Chimia|October 27, 2017
The Screening Compound Collection: A Key Asset for Drug DiscoveryChristoph Boss, Julien Hazemann, Thierry Kimmerlin, et al.
Pageof 2